Insider Transactions in Q2 2021 at Rhythm Pharmaceuticals, Inc. (RYTM)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 21
2021
|
Hunter C Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.45%
|
$30,000
$6.88 P/Share
|